← Back to Search

Behavioral Intervention

ACT-Based PrEP Intervention for HIV Prevention

N/A

Recruiting

Led By Trisha Arnold, PhD

Research Sponsored by Rhode Island Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Male sex assigned at birth

Not taken PrEP in past 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 week visit

Awards & highlights

Study Summary

This trial will adapt and test a brief Acceptance and Commitment Therapy (ACT)-based culturally appropriate pre-exposure prophylaxis (PrEP) intervention for young Black men who have sex with men (YBMSM).

Who is the study for?

This trial is for young Black men, aged 18-34, who have sex with men and are interested in HIV prevention. They must not have taken PrEP in the past 3 months, be English-speaking, assigned male at birth, and meet CDC guidelines for PrEP use. Those already in another PrEP study or unable to consent are excluded.Check my eligibility

What is being tested?

The trial is testing a new Acceptance and Commitment Therapy (ACT)-based intervention called ACTPrEP against an enhanced standard of care. It's designed specifically for young Black MSM to increase engagement with Pre-exposure Prophylaxis (PrEP) as an HIV preventive measure.See study design

What are the potential side effects?

Since this trial focuses on behavioral intervention rather than medication, traditional side effects like those seen with drugs aren't expected. Participants may experience emotional discomfort discussing personal topics during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was assigned male at birth.

Select...

I have not taken PrEP in the last 3 months.

Select...

I am between 18 and 34 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 week visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 week visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 week visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

ACTPrEP Acceptability

ACTPrEP Feasibility

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ACTPrEPExperimental Treatment1 Intervention

ACTPrEP will include a 60-minute initial session and 30-minute sessions at 2, 6, and 12 weeks.

Group II: Control GroupActive Control1 Intervention

Control group will include one 30-minute PrEP education session.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor

260 Previous Clinical Trials

66,941 Total Patients Enrolled

University of Mississippi Medical CenterOTHER

173 Previous Clinical Trials

195,021 Total Patients Enrolled

Trisha Arnold, PhDPrincipal InvestigatorRhode Island Hospital

Media Library

ACTPrEP (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05087680 — N/A

HIV Prevention Research Study Groups: Control Group, ACTPrEP

HIV Prevention Clinical Trial 2023: ACTPrEP Highlights & Side Effects. Trial Name: NCT05087680 — N/A

ACTPrEP (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05087680 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor still recruiting participants?

"Currently, clinicaltrials.gov does not list this trial as actively recruiting patients; the original post date was October 1st 2022 and it was most recently updated on April 27th 2022. However, there are 24 other studies seeking participants at present."

Answered by AI

Is this research study open to participants aged 55 and over?

"This investigation into novel treatments has a strict age requirement; all participants must be between 18 and 34 years old."

Answered by AI

Is there a specific demographic of people eligible to participate in this experiment?

"This clinical trial is seeking individuals between 18 and 34 who currently have HIV prevention, with 66 people needed in total. The additional requirements are that they must not be a part of another Prep related study; abstain from taking PrEP for the past 3 months; able to provide consent; and within the age bracket specified."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South

2023. "An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05087680.